/CNGGF
CNGGF Stock - Cann Group Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.01+0.00%
+$0.00 (+0.00%) • Dec 19
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.7
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CNGGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.12
52W High$0.03
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.25M | $15.37M | $20.63M | $11.24M | $8.57M |
| Gross Profit | $5.15M | $6.18M | $5.54M | $11.24M | $8.52M |
| Gross Margin | 38.9% | 40.2% | 26.8% | 100.0% | 99.4% |
| Operating Income | $-8,942,000 | $-13,479,000 | $-17,766,000 | $-19,450,000 | $-16,639,000 |
| Net Income | $-22,345,000 | $-51,242,000 | $-33,790,000 | $-26,468,000 | $-25,103,000 |
| Net Margin | -168.6% | -333.3% | -163.8% | -235.5% | -293.0% |
| EPS | $-0.04 | $-0.11 | $-0.09 | $-0.08 | $-0.10 |
Company Overview
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CNGGFBeat Rate
0%
Last 1 quarters
Avg Surprise
-6.1%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
-6.1%
$-0.04vs$-0.03
Q2 23
No data
Q2 24
No data
Q4 24
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q3 2025 | Sep 1, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Oct 22, 2024 | — | $-0.06 | — | — |
Q2 2024 | May 8, 2024 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 31, 2022 | $-0.03 | $-0.04 | -6.1% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | — | $-0.04 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.03 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.03 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.02 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.01 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.02 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.02 | — | — |
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
📈 PositiveBenzinga•Dec 18, 2025, 12:21 PM•Also: , ,
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
📈 PositiveBenzinga•Dec 17, 2025, 01:38 PM•Also: , ,
Frequently Asked Questions about CNGGF
What is CNGGF's current stock price?
Cann Group Limited (CNGGF) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for CNGGF?
No analyst price targets are currently available for this stock.
What sector is Cann Group Limited in?
Cann Group Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CNGGF's market cap?
Cann Group Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does CNGGF pay dividends?
No, Cann Group Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVTBF
Avant Brands Inc.
$0.74
Mkt Cap: $0.0B
CLABF
Core One Labs Inc.
$0.00
Mkt Cap: $0.0B
CPIVF
Captiva Verde Wellness Corp.
$0.02
Mkt Cap: $0.0B
CTABF
Canntab Therapeutics Limited
$0.00
Mkt Cap: $0.0B
LIFD
LFTD Partners Inc.
$0.23
Mkt Cap: $0.0B
RPNRF
Rapid Nutrition PLC
$0.01
Mkt Cap: $0.0B
RVVTF
Revive Therapeutics Ltd.
$0.01
Mkt Cap: $0.0B
STHZF
StateHouse Holdings Inc.
$0.00
Mkt Cap: $0.0B
TGIFF
1933 Industries Inc.
$0.01
Mkt Cap: $0.0B
TNRG
Thunder Energies Corporation
$0.00
Mkt Cap: $0.0B
Explore stocks similar to CNGGF for comparison